Incyte to Report First Quarter Financial Results
Incyte (INCY) schedules first quarter financial results conference call and webcast on April 30, 2024, providing details for participation and access to replays.
04/11/2024 - 08:00 AM
WILMINGTON, Del. --(BUSINESS WIRE)--
Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, April 30, 2024.
The schedule for the press release and conference call/webcast is as follows:
• Q1 2024 Press Release:
April 30, 2024 at 7:00 a.m. ET
• Q1 2024 Conference Call:
April 30, 2024 at 8:00 a.m. ET
• Domestic Dial-In Number:
877-407-3042
• International Dial-In Number:201-389-0864
• Conference ID Number:13745743
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13745743.
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
About Incyte
A global biopharmaceutical company on a mission to Solve On. , Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware , Incyte has operations in North America , Europe and Asia .
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn , X , Instagram , Facebook , YouTube .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240411369652/en/
Media
media@incyte.com
Investors
ir@incyte.com
Source: Incyte
When is Incyte's first quarter financial results conference call and webcast scheduled?
Incyte's first quarter financial results conference call and webcast are scheduled for 8:00 a.m. ET on Tuesday, April 30, 2024.
What are the details for the Q1 2024 Press Release?
The Q1 2024 Press Release is scheduled for April 30, 2024, at 7:00 a.m. ET.
How can I access the live webcast with slides?
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
What are the dial-in numbers for the conference call replay?
The replay dial-in number for the U.S. is 877-660-6853, and for international callers, it is 201-612-7415.
INCY Rankings
#3820 Ranked by Stock Gains
INCY Stock Data
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Sector
Professional, Scientific, and Technical Services
Tags
Health Technology, Biotechnology
Country
US
City
Wilmington
About INCY
incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. we have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. the incyte corporate headquarters is located in wilmington, delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders. for more information about incyte, please visit our corporate website at www.incyte.com.
